Duffull SB - Search Results

1

Development of a bayesian forecasting method for warfarin dose individualization.

Wright DF, Duffull SB. Wright DF, et al. Among authors: duffull sb. Pharm Res. 2011 May;28(5):1100-11. doi: 10.1007/s11095-011-0369-x. Epub 2011 Feb 8. Pharm Res. 2011. PMID: 21301936

2

A sequential Bayesian algorithm for dose individualisation of carboplatin.

Duffull SB, Begg EJ, Robinson BA, Deely JJ. Duffull SB, et al. Cancer Chemother Pharmacol. 1997;39(4):317-26. doi: 10.1007/s002800050578. Cancer Chemother Pharmacol. 1997. PMID: 9025772

3

Comparison of two Bayesian approaches to dose-individualization for once-daily aminoglycoside regimens.

Duffull SB, Kirkpatrick CM, Begg EJ. Duffull SB, et al. Br J Clin Pharmacol. 1997 Feb;43(2):125-35. doi: 10.1046/j.1365-2125.1997.05341.x. Br J Clin Pharmacol. 1997. PMID: 9131944 Free PMC article. Clinical Trial.

4

Clinical pharmacokinetics and dose optimisation of carboplatin.

Duffull SB, Robinson BA. Duffull SB, et al. Clin Pharmacokinet. 1997 Sep;33(3):161-83. doi: 10.2165/00003088-199733030-00002. Clin Pharmacokinet. 1997. PMID: 9314610 Review.

5

Development of a general method of limited sampling for the determination of AUC for a drug that displays two-compartment pharmacokinetics.

Duffull SB, Begg EJ, Deely JJ. Duffull SB, et al. Eur J Clin Pharmacol. 1999 May;55(3):213-9. doi: 10.1007/s002280050620. Eur J Clin Pharmacol. 1999. PMID: 10379637

6

Development of a sequential linked pharmacokinetic and pharmacodynamic simulation model for ivabradine in healthy volunteers.

Duffull SB, Aarons L. Duffull SB, et al. Eur J Pharm Sci. 2000;10(4):275-84. doi: 10.1016/s0928-0987(00)00085-3. Eur J Pharm Sci. 2000. PMID: 10838017 Clinical Trial.

7

A pharmacokinetic simulation model for ivabradine in healthy volunteers.

Duffull SB, Chabaud S, Nony P, Laveille C, Girard P, Aarons L. Duffull SB, et al. Eur J Pharm Sci. 2000;10(4):285-94. doi: 10.1016/s0928-0987(00)00086-5. Eur J Pharm Sci. 2000. PMID: 10838018 Clinical Trial.

8

The effect of body weight on dalteparin pharmacokinetics. A preliminary study.

Yee JY, Duffull SB. Yee JY, et al. Among authors: duffull sb. Eur J Clin Pharmacol. 2000 Jul;56(4):293-7. doi: 10.1007/s002280000141. Eur J Clin Pharmacol. 2000. PMID: 10954342

9

Optimal design of a population pharmacodynamic experiment for ivabradine.

Duffull SB, Mentré F, Aarons L. Duffull SB, et al. Pharm Res. 2001 Jan;18(1):83-9. doi: 10.1023/a:1011035028755. Pharm Res. 2001. PMID: 11336357

10

Modeling and stimulation for clinical trial design involving a categorical response: a phase II case study with naratriptan.

Nestorov I, Graham G, Duffull S, Aarons L, Fuseau E, Coates P. Nestorov I, et al. Pharm Res. 2001 Aug;18(8):1210-9. doi: 10.1023/a:1010943430471. Pharm Res. 2001. PMID: 11587494

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results